Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-20

FDA Approved: CARISOPRODOL TABLETS, USP, 350 MG — Original Application (Granulation Technology, Inc.)

View source ↗

Summary

The FDA approved an original ANDA for Carisoprodol Tablets, USP, 350 mg, establishing a generic version of the muscle relaxant for short-term relief of acute mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carisoprodol Tablets, USP, 350 mg (carisoprodol)

Snippet

ORIG AP for CARISOPRODOL TABLETS, USP, 350 MG (CARISOPRODOL)